AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 144 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1 | – | 430 | -11.3% | 0.00% | – |
Q1 2023 | $0 | -100.0% | 485 | -85.2% | 0.00% | – |
Q3 2022 | $6,000 | -70.0% | 3,281 | -49.6% | 0.00% | – |
Q2 2022 | $20,000 | -96.7% | 6,511 | -95.5% | 0.00% | -100.0% |
Q1 2022 | $599,000 | +29.1% | 143,731 | +48.2% | 0.00% | – |
Q4 2021 | $464,000 | +5700.0% | 96,998 | +7896.5% | 0.00% | – |
Q1 2021 | $8,000 | -90.7% | 1,213 | -93.6% | 0.00% | – |
Q4 2020 | $86,000 | +87.0% | 18,905 | +57.1% | 0.00% | – |
Q3 2020 | $46,000 | +318.2% | 12,030 | +395.7% | 0.00% | – |
Q2 2020 | $11,000 | -42.1% | 2,427 | -55.6% | 0.00% | – |
Q1 2020 | $19,000 | -52.5% | 5,461 | -35.6% | 0.00% | – |
Q4 2019 | $40,000 | +300.0% | 8,475 | +142.0% | 0.00% | – |
Q3 2019 | $10,000 | -68.8% | 3,502 | -23.0% | 0.00% | – |
Q2 2019 | $32,000 | -61.4% | 4,550 | -22.5% | 0.00% | – |
Q1 2019 | $83,000 | +25.8% | 5,869 | +19.3% | 0.00% | – |
Q4 2018 | $66,000 | -89.1% | 4,920 | -82.0% | 0.00% | -100.0% |
Q3 2018 | $608,000 | +36.9% | 27,405 | +1.1% | 0.00% | 0.0% |
Q2 2018 | $444,000 | – | 27,108 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 21,521,301 | $90,819,890 | 14.58% |
Eversept Partners, LP | 2,644,988 | $11,161,849 | 0.94% |
TPG GP A, LLC | 12,328,767 | $52,027,397 | 0.90% |
Nantahala Capital Management | 2,212,757 | $9,337,835 | 0.80% |
Rubric Capital Management LP | 4,024,500 | $16,983,390 | 0.64% |
Hedges Asset Management LLC | 84,600 | $357,012 | 0.31% |
Signature Wealth Management Partners, LLC | 66,666 | $281,331 | 0.28% |
Tejara Capital Ltd | 96,672 | $407,956 | 0.23% |
Tranquilli Financial Advisor LLC | 71,414 | $301,367 | 0.22% |
EAM Investors, LLC | 230,271 | $971,744 | 0.19% |